1.Identification of the chemical constituents of Fangfeng-Tongsheng Pills by ultra-high performance liquid chromatography coupled with hybrid quadrupole-orbitrap mass spectrometry
Wenning YANG ; Qianwan MENG ; Wenshuai TIAN ; Dandan ZHOU
International Journal of Traditional Chinese Medicine 2020;42(7):670-678
Objective:To identify the chemical constituents of Fangfeng-Tongsheng Pills by ultra-high performance liquid chromatography coupled with hybrid quadrupole-orbitrap mass spectrometry (UPLC-Q-Orbitrap HRMS). Methods:Take Agilent InfinityLab Poroshell 120 C18 column (150 mm×3.0 mm, 2.7 μm) and make water containing 0.1% formic acid and acetonitrile as gradient eluents. Data was collected with positive and negative ion modes using full scan and two-stage threshold-triggered mass modes (Full MS/dd-MS 2) and HESI source. The main chemical constituents of Fangfeng-Tongsheng Pills were identified according to the exact molecular mass, the cleavage fragments of MS 2, the retention time of reference substances, mzVault 2.0 MS database and literature review. Results:A total of 82 chemical constituents including 33 flavonoids, 13 chromones, 8 triterpenoid saponins, 6 coumarin, 5 iridoids, 4 phthalides, 4 terpenoids, 3 phenolic acids, 3 lignans, 2 anthraquinone and 1 alkaloids, were detected and identified.Conclusions:UPLC-Q-Orbitrap HRMS could identify the main chemical constituents of Fangfeng-Tongsheng Pills rapidly and accurately, which may provide a theoretical basis for further studies on the mechnism and quality control of this formula.
2.Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
Xiuxiu WU ; Wenshuai XU ; Jun WANG ; Xinlun TIAN ; Zhuang TIAN ; Kaifeng XU
Frontiers of Medicine 2019;13(2):259-266
Lymphangioleiomyomatosis (LAM) is a rare diffuse cystic lung disease. Knowledge on LAM-related pulmonary hypertension (PH) is limited. This study aimed to analyze the clinical characteristics of LAM with elevated pulmonary artery pressure (PAP) and evaluate the potential efficacy of sirolimus. The study involved 50 LAM patients who underwent echocardiography. According to the tricuspid regurgitation velocity (TRV), these patients were divided into the TRV ⩽ 2.8 m/s group and TRV > 2.8 m/s group. Both groups comprised 25 females with an average age of 38.6 ± 8.1 and 41.5 ± 8.9 years. In the TRV > 2.8 m/s group, the estimated systolic PAP (SPAP) was significantly elevated (52.08 ± 12.45 mmHg vs. 30.24 ± 5.25 mmHg, P < 0.01). Linear analysis showed that SPAP was correlated with forced expiratory volume in 1 s (FEV), diffusing capacity of the lungs for carbon monoxide, alveolar arterial oxygen gradient (PO), and 6 min walking distance (r =-0.392, -0.351, 0.450, and -0.591, respectively; P < 0.05), in which PO was a risk factor for SPAP elevation (β = 0.064, OR = 1.066, P < 0.05). Moreover, in 10 patients who received sirolimus therapy, SPAP decreased from 57.0 12.6 mmHg to 35.2 ± 11.1 mmHg. The study showed that LAM patients with PH exhibit poor pulmonary function and hypoxemia and may benefit from sirolimus treatment.
Adult
;
Carbon Monoxide
;
analysis
;
Echocardiography
;
Exercise Test
;
Female
;
Hemodynamics
;
Humans
;
Hypertension, Pulmonary
;
physiopathology
;
therapy
;
Logistic Models
;
Lymphangioleiomyomatosis
;
physiopathology
;
therapy
;
Male
;
Middle Aged
;
Multivariate Analysis
;
Oxygen
;
blood
;
therapeutic use
;
Respiratory Function Tests
;
Sirolimus
;
therapeutic use
3.Lung function and air pollution exposure in adults with asthma in Beijing: a 2-year longitudinal panel study.
Jun WANG ; Wenshuai XU ; Xinlun TIAN ; Yanli YANG ; Shao-Ting WANG ; Kai-Feng XU
Frontiers of Medicine 2022;16(4):574-583
The effect of air pollution on the lung function of adults with asthma remains unclear to date. This study followed 112 patients with asthma at 3-month intervals for 2 years. The pollutant exposure of the participants was estimated using the inverse distance weight method. The participants were divided into three groups according to their lung function level at every visit. A linear mixed-effect model was applied to predict the change in lung function with each unit change in pollution concentration. Exposure to carbon monoxide (CO) and particles less than 2.5 micrometers in diameter (PM2.5) was negatively associated with large airway function in participants. In the severe group, exposure to chronic sulfur dioxide (SO2) was negatively associated with post-bronchodilator forced expiratory flow at 50%, between 25% and 75% of vital capacity % predicted (change of 95% CI per unit: -0.34 (-0.55, -0.12), -0.24 (-0.44, -0.03), respectively). In the mild group, the effect of SO2 on the small airways was similar to that in the severe group, and it was negatively associated with large airway function. Exposure to CO and PM2.5 was negatively associated with the large airway function of adults with asthma. The negative effects of SO2 were more evident and widely observed in adults with severe and mild asthma than in adults with moderate asthma. Patients with asthma react differently to air pollutants as evidenced by their lung function levels.
Adult
;
Air Pollutants/analysis*
;
Air Pollution/adverse effects*
;
Asthma/epidemiology*
;
Beijing/epidemiology*
;
Environmental Exposure/adverse effects*
;
Humans
;
Lung
;
Particulate Matter/analysis*
;
Sulfur Dioxide/adverse effects*
4.Novel mutation c.1210-3C > G in cis with a poly-T tract of 5T affects CFTR mRNA splicing in a Chinese patient with cystic fibrosis.
Xinyue ZHAO ; Keqiang LIU ; Wenshuai XU ; Meng XIAO ; Qianli ZHANG ; Jiaxing SONG ; Keqi CHEN ; Yaping LIU ; Xinlun TIAN ; Kai-Feng XU ; Xue ZHANG
Frontiers of Medicine 2022;16(1):150-155
Cystic fibrosis (CF) is a rare autosomal recessive disease with only one pathogenic gene cystic fibrosis transmembrane conductance regulator (CFTR). To identify the potential pathogenic mutations in a Chinese patient with CF, we conducted Sanger sequencing on the genomic DNA of the patient and his parents and detected all 27 coding exons of CFTR and their flanking intronic regions. The patient is a compound heterozygote of c.2909G > A, p.Gly970Asp in exon 18 and c.1210-3C > G in cis with a poly-T of 5T (T5) sequence, 3 bp upstream in intron 9. The splicing effect of c.1210-3C > G was verified via minigene assay in vitro, indicating that wild-type plasmid containing c.1210-3C together with T7 sequence produced a normal transcript and partial exon 10-skipping-transcript, whereas mutant plasmid containing c.1210-3G in cis with T5 sequence caused almost all mRNA to skip exon 10. Overall, c.1210-3C > G, the newly identified pathogenic mutation in our patient, in combination with T5 sequence in cis, affects the CFTR gene splicing and produces nearly no normal transcript in vitro. Moreover, this patient carries a p.Gly970Asp mutation, thus confirming the high-frequency of this mutation in Chinese patients with CF.
China
;
Cystic Fibrosis/genetics*
;
Cystic Fibrosis Transmembrane Conductance Regulator/genetics*
;
Humans
;
Mutation
;
Poly T
;
RNA, Messenger/genetics*
5.Lack of CFAP54 causes primary ciliary dyskinesia in a mouse model and human patients.
Xinyue ZHAO ; Haijun GE ; Wenshuai XU ; Chongsheng CHENG ; Wangji ZHOU ; Yan XU ; Junping FAN ; Yaping LIU ; Xinlun TIAN ; Kai-Feng XU ; Xue ZHANG
Frontiers of Medicine 2023;17(6):1236-1249
Primary ciliary dyskinesia (PCD) is a highly heterogeneous recessive inherited disorder. FAP54, the homolog of CFAP54 in Chlamydomonas reinhardtii, was previously demonstrated as the C1d projection of the central microtubule apparatus of flagella. A Cfap54 knockout mouse model was then reported to have PCD-relevant phenotypes. Through whole-exome sequencing, compound heterozygous variants c.2649_2657delinC (p. E883Dfs*47) and c.7312_7313insCGCAGGCTGAATTCTTGG (p. T2438delinsTQAEFLA) in a new suspected PCD-relevant gene, CFAP54, were identified in an individual with PCD. Two missense variants, c.4112A>C (p. E1371A) and c.6559C>T (p. P2187S), in CFAP54 were detected in another unrelated patient. In this study, a minigene assay was conducted on the frameshift mutation showing a reduction in mRNA expression. In addition, a CFAP54 in-frame variant knock-in mouse model was established, which recapitulated the typical symptoms of PCD, including hydrocephalus, infertility, and mucus accumulation in nasal sinuses. Correspondingly, two missense variants were deleterious, with a dramatic reduction in mRNA abundance from bronchial tissue and sperm. The identification of PCD-causing variants of CFAP54 in two unrelated patients with PCD for the first time provides strong supportive evidence that CFAP54 is a new PCD-causing gene. This study further helps expand the disease-associated gene spectrum and improve genetic testing for PCD diagnosis in the future.
Mice
;
Animals
;
Humans
;
Male
;
Kartagener Syndrome/metabolism*
;
Cilia/metabolism*
;
Semen
;
Genetic Testing
;
RNA, Messenger
;
Mutation